An esterase-activatable curcumin prodrug for tumor-targeting therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Chemical communications"
DOI: 10.1039/d2cc03952d
Abstract: A tumor-targeting therapy strategy is urgently needed to increase the accumulation of drugs in tumors and reduce the side effects in normal tissues. Herein, we developed an esterase-activatable curcumin prodrug Cur-RGD for tumor-targeting therapy. Armed… read more here.
Keywords: esterase activatable; activatable curcumin; tumor targeting; targeting therapy ... See more keywords